Skip to main content
. 2024 Feb 19;38:101281. doi: 10.1016/j.conctc.2024.101281

Table 1.

Summary of observed accrual performance of cancer clinical trials at the KUCC by evaluation year.

Evaluation Year Number of Clinical Trials Observed Accrual Performance: Median (Min, Max)
2018 76 0.204 (0, 2.502)
2019 91 0.230 (0, 6.471)
2020 107 0.177 (0, 8.177)
2021 104 0.077 (0, 8.156)
2022 75 0.276 (0, 2.227)
2023 79 0.326 (0, 11.102)